All Posts Tagged With: "STJ"
(STJ) St. Jude Medical’s New Quadra Study
St. Jude Medical (STJ) has enrolled the first patient for its MultiPoint Pacing clinical study. The study will evaluate the efficacy of the company’s Quadripolar Pacing system belonging to the implantable cardioverter defibrillator...17May2013 | vitalstocks | Comments Off | Continued
(LIFE) MedTech Industry Stock Update – May 2013 – Zacks Analyst Interviews
As expected, MedTech mergers and acquisitions (M&A) are heating up in 2013. Finally, the much-hyped takeover battle for Life Technologies Corporation (LIFE) came to an end last month with Thermo Fisher Scientific...15May2013 | vitalstocks | Comments Off | Continued
(STJ) Will St. Jude Beat Earnings this Quarter?
St. Jude Medical Inc. (STJ) is set to report its first-quarter 2013 results before the opening bell on Wednesday, Apr 17. Let us see how things are shaping up prior to the announcement. In the last quarter, the medical device...27Apr2013 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Medical Begins EnligHTN II Trial
St. Jude Medical Inc. (STJ) has initiated the EnligHTN II trail with the enrolment of first patient to further evaluate its renal denervation technology in treating uncontrolled hypertension. This follows the successful EnligHTN I...16Feb2013 | Shawn | Comments Off | Continued
(JNJ) MedTech Industry Stock Outlook – January 2013 – Zacks Analyst Interviews
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide medical devices market. The US still holds the leading position with almost one-third of the market share. However, emerging economies like Brazil, Russia, India and China –...31Jan2013 | Shawn | Comments Off | Continued
(STJ) St. Jude Medical’s Products Earn CE Mark Approval
St. Jude Medical (STJ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Both the products were unveiled...26Jan2013 | Shawn | Comments Off | Continued
(AAPL) Fourth Quarter 2012 Earnings Season Gets Into High Gear – Earnings Preview
The fourth quarter reporting season gets into high gear this week, with 253 companies coming out with quarterly results, including 83 S&P 500 companies. The earnings season thus far has been relatively uneventful, but we will have a better idea by the end of this week; by then we will have seen...20Jan2013 | Shawn | Comments Off | Continued
(BSX) Boston Scientific Corporation Initiates Ingevity Trial
Boston Scientific Corporation (BSX) recently commenced a trial for its next-generation Ingevity pacing leads. The first patient was implanted to evaluate the safety, effectiveness and ...27Dec2012 | Shawn | Comments Off | Continued
(STJ) St. Jude Medical Wins CE Mark Approval for Assura
Medical devices major, St. Jude Medical (STJ) recently won the European CE Mark approval for its line of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators...4Dec2012 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Medical Earnings Preview
Medical device major, St. Jude Medical (STJ) is slated to announce its third quarter results before the opening bell on Wednesday, October 17. The current Zacks Consensus Estimate for the third quarter is 80 cents, representing estimated...31Oct2012 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Medical Reports Positive Data
Medical devices major, St. Jude Medical, Inc. (STJ) recently announced results from a large-scale clinical study of peripheral nerve stimulus (PNS) of the occipital nerve for managing pain and disability associated with chronic migraine,...8Oct2012 | vitalstocks | Comments Off | Continued
(SNN) MedTech Industry Stock Outlook – October 2012 – Zacks Analyst Interviews
The global medical devices industry is fairly large, intensely competitive and highly innovative. A regulated industry, MedTech is spread across different segments including cardiology, cardiovascular, neuro, orthopedic and aesthetic devices. The US medical devices industry relies largely on an aging...4Oct2012 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Medical Realigns Units – Cuts Jobs
Medical devices major, St. Jude Medical, Inc. (STJ) recently announced that it will consolidate its four operating segments into two units as a part of its cost-cutting measure to leverage future growth. The company also changed the...18Sep2012 | vitalstocks | Comments Off | Continued
(CRY) CryoLife Initiates Dividend
CryoLife, Inc. (CRY), a medical devices company which specializes in preserving and processing tissues, recently announced that its Board has approved the initiation of quarterly cash dividend of 2.5 cents per share. The company foresees...22Aug2012 | vitalstocks | Comments Off | Continued
(ZMH) Zimmer Holdings Posts Mixed Second Quarter – Tightens View
Zimmer Holdings (ZMH) reported earnings per share (“EPS”) of $1.22 in the second quarter of fiscal 2012 compared with $1.06 in the year-ago quarter. After taking into account certain one-time items, adjusted EPS came in at $1.34,...22Aug2012 | vitalstocks | Comments Off | Continued
(GB) Greatbatch’s Second Quarter Earnings Mixed – Profit Drops
Greatbatch, Inc. (GB) reported second-quarter 2012 adjusted (excluding one-time items) earnings per share of 43 cents, in line with both the Zacks Consensus Estimate and the year-ago adjusted earnings. Profits (as reported) plunged...22Aug2012 | vitalstocks | Comments Off | Continued
(MDT) Medtronic Meets Earnings Forecasts
Medtronic Inc. (MDT) reported first quarter fiscal 2013 earnings per share of 83 cents, up 8% year over year. After taking into account certain one-time items, the adjusted EPS was 85 cents, also up 8% year over year and in...21Aug2012 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Medical Beats by a Penny – Trims Outlook
Medical devices major, St. Jude Medical, Inc.’s (STJ) second quarter 2012 adjusted earnings of 88 cents per share beat the Zacks Consensus Estimate by a penny and surpassed the year-ago earnings of 85 cents per share. Earnings were...13Aug2012 | vitalstocks | Comments Off | Continued
(GB) Greatbatch to Build Research and Development Center
Medical technologies company, Greatbatch Inc. (GB) recently announced that it will set up an Active Implantable Medical Device (“AIMD”) Research and Development (“R&D”) Centre in Singapore. It will be Greatbatch’s first...23Jul2012 | vitalstocks | Comments Off | Continued
(MDT) Medtronic Hikes Dividend
Leading medical device player, Medtronic (MDT) announced a 7.2% increase in its cash dividend for fiscal 2013. With this hike, the dividend for the quarter comes to 26 cents per share or $1.04 per share for fiscal 2013, up from 97...26Jun2012 | vitalstocks | Comments Off | Continued
(JNJ) MedTech Stock Outlook – June 2012 – Industry Outlook
Over the recent past, medical technology (MedTech) players have faced the brunt of exigent economic conditions and a precarious healthcare environment. The performance of the players was thereby hamstrung by several macro issues, including sustained price erosion and procedure volume pressures. The...16Jun2012 | vitalstocks | Comments Off | Continued
(MDT) Medtronic Posts Mixed Numbers
Medtronic Inc. (MDT) reported fourth quarter fiscal 2012 earnings per share (EPS) of 94 cents, up 31% year over year. However, adjusted EPS during the quarter came in at 99 cents, 10% above the year-ago period...28May2012 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Medical Build on Alliance with Abbott Laboratories
St. Jude Medical Inc. (STJ) recently disclosed its decision to build on its mutual agreement with Abbott Laboratories (ABT) by revealing the long-term Choice Alliance...28Apr2012 | vitalstocks | Comments Off | Continued
(STJ) St. Jude Beats The Street – Raises Guidance
St. Jude Medical, Inc. (STJ), a large-cap medical devices and technology development company, reported first quarter fiscal 2012 adjusted earnings of 86 cents beating the Zacks Consensus Estimate of 83 cents per share and surpassing...20Apr2012 | vitalstocks | Comments Off | Continued
(MDT) MedTech Industry Stock Outlook – March 2012 – Zacks Analyst Interviews
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The...19Mar2012 | vitalstocks | Comments Off | Continued
(MDT) MedTech Industry Stock Outlook – March 2012 – Industry Outlook
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The...8Mar2012 | vitalstocks | Comments Off | Continued
(GB) Greatbatch Buying NeuroNexus
Medical technology company Greatbatch (GB) is acquiring Michigan-based implantable medical device design firm NeuroNexus Technologies for roughly $12 million. The deal includes assumption of debt and future considerations (undisclosed). NeuroNexus,...23Feb2012 | vitalstocks | 0 comments | Continued
(STJ) St. Jude Medical Fourth Quarter 2011 Earnings Scorecard
Medical devices major St. Jude Medical’s (STJ) fourth-quarter 2011 adjusted earnings per share of 86 cents beat the Zacks Consensus Estimate by a couple of cents and exceeded the year-ago earnings of 75 cents. Highlights...6Feb2012 | vitalstocks | 0 comments | Continued
(STJ) New Year Bets from MedTech
Picking the right stock is never easy, especially in a difficult and volatile market. There are thousands of stocks to choose from and many investors eventually end up boiling the ocean. The U.S. economy continues to be cramped by a spate of headwinds including a still unstable job market,...6Jan2012 | vitalstocks | 0 comments | Continued
(STJ) Christmas Gift for the Ailing Heart
Wilson Greatbatch, the self-professed “humble tinkerer” and a trailblazer in medical technology, invented the first implantable cardiac pacemaker in 1958 which kept the rhythm of millions of heartbeats and preserved countless lives across the planet. A couple of decades later, the...14Dec2011 | vitalstocks | 0 comments | Continued